Viewing data from:

CHLOROQUINE PHOSPHATE

ANDA

CHLOROQUINE PHOSPHATE | A040516 | IMPAX LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Chloroquine Phosphate (2023)

Total Spending

$578K

Total Claims

3,448

Beneficiaries

1,536

Avg Cost/Unit

$6.28

Spending Trend

$647K(2019)→$1.0M(2020)→$783K(2021)→$653K(2022)→$578K(2023)

YoY Change:-3.8%

5yr CAGR:+6.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

IPCA LABORATORIES LTDCHLOROQUINE PHOSPHATE USP

DMF 92351991

NATCO PHARMA LTDCHLOROQUINE PHOSPHATE

DMF 330672019

COHANCE LIFESCIENCES LTDCHLOROQUINE PHOSPHATE USP

DMF 341302019

ICN HUNGARY CO LTDInactiveCHLOROQUINE PHOSPHATE

DMF 104721993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 29, 2003

No patent or exclusivity listings for this strength.